HEADER TRANSFERASE/PEPTIDE 17-JUN-11 3ZRL TITLE IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK-3BETA TITLE 2 INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 23-393; COMPND 5 SYNONYM: GSK-3 BETA; COMPND 6 EC: 2.7.11.26; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PROTO-ONCOGENE FRAT1; COMPND 10 CHAIN: X, Y; COMPND 11 FRAGMENT: RESIDUES 197-226; COMPND 12 SYNONYM: FREQUENTLY REARRANGED IN ADVANCED T-CELL LYMPHOMAS 1, FRAT; COMPND 13 ENGINEERED: YES; COMPND 14 OTHER_DETAILS: FRATTIDE SEQUENCE CO-EXPRESSED IN BACULOVIRUS (DUAL COMPND 15 EXPRESSION) SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 15 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 17 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 18 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE-PEPTIDE COMPLEX, KINASE EXPDTA X-RAY DIFFRACTION AUTHOR G.GENTILE,G.BERNASCONI,A.POZZAN,G.MERLO,P.MARZORATI,P.BAMBOROUGH, AUTHOR 2 B.BAX,A.BRIDGES,C.BROUGH,P.CARTER,G.CUTLER,M.NEU,M.TAKADA REVDAT 4 23-OCT-24 3ZRL 1 REMARK REVDAT 3 20-DEC-23 3ZRL 1 REMARK LINK REVDAT 2 25-APR-12 3ZRL 1 JRNL REMARK VERSN REVDAT 1 29-JUN-11 3ZRL 0 JRNL AUTH G.GENTILE,G.BERNASCONI,A.POZZAN,G.MERLO,P.MARZORATI, JRNL AUTH 2 P.BAMBOROUGH,B.BAX,A.BRIDGES,C.BROUGH,P.CARTER,G.CUTLER, JRNL AUTH 3 M.NEU,M.TAKADA JRNL TITL IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS JRNL TITL 2 GSK-3BETA INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 21 4823 2011 JRNL REFN ISSN 0960-894X JRNL PMID 21764580 JRNL DOI 10.1016/J.BMCL.2011.06.050 REMARK 2 REMARK 2 RESOLUTION. 2.48 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.3.0006 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.48 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 30190 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1286 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.48 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2188 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.69 REMARK 3 BIN R VALUE (WORKING SET) : 0.2170 REMARK 3 BIN FREE R VALUE SET COUNT : 100 REMARK 3 BIN FREE R VALUE : 0.3110 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5905 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 198 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.04 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.57000 REMARK 3 B22 (A**2) : -0.57000 REMARK 3 B33 (A**2) : 0.86000 REMARK 3 B12 (A**2) : -0.29000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.543 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.290 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.186 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.062 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.906 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6316 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8619 ; 1.289 ; 1.991 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 770 ; 5.710 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 280 ;34.921 ;22.857 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1051 ;16.840 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 54 ;22.344 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 953 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4895 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2721 ; 0.201 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4303 ; 0.306 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 296 ; 0.134 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 50 ; 0.217 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.167 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3940 ; 1.184 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 6256 ; 2.377 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2691 ; 3.603 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2363 ; 4.966 ; 8.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 3ZRL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1290048717. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0723 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31542 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.480 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.48 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.52 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : 0.43000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.920 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1GNG REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z REMARK 290 6555 -X,-X+Y,-Z REMARK 290 7555 X+2/3,Y+1/3,Z+1/3 REMARK 290 8555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 9555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 10555 Y+2/3,X+1/3,-Z+1/3 REMARK 290 11555 X-Y+2/3,-Y+1/3,-Z+1/3 REMARK 290 12555 -X+2/3,-X+Y+1/3,-Z+1/3 REMARK 290 13555 X+1/3,Y+2/3,Z+2/3 REMARK 290 14555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 15555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 16555 Y+1/3,X+2/3,-Z+2/3 REMARK 290 17555 X-Y+1/3,-Y+2/3,-Z+2/3 REMARK 290 18555 -X+1/3,-X+Y+2/3,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 76.61550 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 44.23398 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 67.24300 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 76.61550 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 44.23398 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 67.24300 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 76.61550 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 44.23398 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 67.24300 REMARK 290 SMTRY1 10 -0.500000 0.866025 0.000000 76.61550 REMARK 290 SMTRY2 10 0.866025 0.500000 0.000000 44.23398 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 67.24300 REMARK 290 SMTRY1 11 1.000000 0.000000 0.000000 76.61550 REMARK 290 SMTRY2 11 0.000000 -1.000000 0.000000 44.23398 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 67.24300 REMARK 290 SMTRY1 12 -0.500000 -0.866025 0.000000 76.61550 REMARK 290 SMTRY2 12 -0.866025 0.500000 0.000000 44.23398 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 67.24300 REMARK 290 SMTRY1 13 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 88.46796 REMARK 290 SMTRY3 13 0.000000 0.000000 1.000000 134.48600 REMARK 290 SMTRY1 14 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 14 0.866025 -0.500000 0.000000 88.46796 REMARK 290 SMTRY3 14 0.000000 0.000000 1.000000 134.48600 REMARK 290 SMTRY1 15 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 15 -0.866025 -0.500000 0.000000 88.46796 REMARK 290 SMTRY3 15 0.000000 0.000000 1.000000 134.48600 REMARK 290 SMTRY1 16 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 16 0.866025 0.500000 0.000000 88.46796 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 134.48600 REMARK 290 SMTRY1 17 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 17 0.000000 -1.000000 0.000000 88.46796 REMARK 290 SMTRY3 17 0.000000 0.000000 -1.000000 134.48600 REMARK 290 SMTRY1 18 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 18 -0.866025 0.500000 0.000000 88.46796 REMARK 290 SMTRY3 18 0.000000 0.000000 -1.000000 134.48600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6320 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 34230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -113.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, X, Y REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 S SO4 B1387 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 23 REMARK 465 GLY A 24 REMARK 465 SER A 25 REMARK 465 MET A 26 REMARK 465 LYS A 27 REMARK 465 VAL A 28 REMARK 465 SER A 29 REMARK 465 ARG A 30 REMARK 465 ASP A 31 REMARK 465 LYS A 32 REMARK 465 ASP A 33 REMARK 465 GLY A 34 REMARK 465 SER A 35 REMARK 465 GLY A 120 REMARK 465 GLU A 121 REMARK 465 ALA A 386 REMARK 465 ALA A 387 REMARK 465 ALA A 388 REMARK 465 SER A 389 REMARK 465 THR A 390 REMARK 465 PRO A 391 REMARK 465 THR A 392 REMARK 465 ASN A 393 REMARK 465 PHE B 23 REMARK 465 GLY B 24 REMARK 465 SER B 25 REMARK 465 MET B 26 REMARK 465 LYS B 27 REMARK 465 VAL B 28 REMARK 465 SER B 29 REMARK 465 ARG B 30 REMARK 465 ASP B 31 REMARK 465 LYS B 32 REMARK 465 ASP B 33 REMARK 465 GLY B 34 REMARK 465 SER B 35 REMARK 465 GLN B 385 REMARK 465 ALA B 386 REMARK 465 ALA B 387 REMARK 465 ALA B 388 REMARK 465 SER B 389 REMARK 465 THR B 390 REMARK 465 PRO B 391 REMARK 465 THR B 392 REMARK 465 ASN B 393 REMARK 465 MET X 195 REMARK 465 ALA X 196 REMARK 465 ASP X 197 REMARK 465 ASP X 198 REMARK 465 SER X 222 REMARK 465 ARG X 223 REMARK 465 ARG X 224 REMARK 465 LEU X 225 REMARK 465 GLN X 226 REMARK 465 MET Y 195 REMARK 465 ALA Y 196 REMARK 465 ASP Y 197 REMARK 465 ASP Y 198 REMARK 465 PRO Y 199 REMARK 465 HIS Y 200 REMARK 465 ARG Y 224 REMARK 465 LEU Y 225 REMARK 465 GLN Y 226 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 36 CG CD CE NZ REMARK 470 LYS A 91 CG CD CE NZ REMARK 470 ARG A 92 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 93 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 94 CG CD CE NZ REMARK 470 LYS A 123 CG CD CE NZ REMARK 470 GLN A 385 CA C O CB CG CD OE1 REMARK 470 GLN A 385 NE2 REMARK 470 LYS B 36 CG CD CE NZ REMARK 470 ARG B 92 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 123 CG CD CE NZ REMARK 470 ILE B 384 CA C O CB CG1 CG2 CD1 REMARK 470 ARG Y 201 CG CD NE CZ NH1 NH2 REMARK 470 ARG Y 223 CA C O CB CG CD NE REMARK 470 ARG Y 223 CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 48 C - N - CA ANGL. DEV. = 18.2 DEGREES REMARK 500 PRO A 48 C - N - CD ANGL. DEV. = -14.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 48 -112.18 22.09 REMARK 500 LYS A 123 -100.64 73.13 REMARK 500 ASP A 124 4.87 -69.98 REMARK 500 ASP A 181 48.82 -147.93 REMARK 500 ASP A 200 74.20 66.15 REMARK 500 CYS A 218 144.25 75.43 REMARK 500 CYS A 218 155.88 77.39 REMARK 500 SER A 236 -18.80 -49.62 REMARK 500 ARG A 308 30.32 -90.21 REMARK 500 ASN A 370 73.35 -167.43 REMARK 500 ASP B 49 -13.85 89.66 REMARK 500 SER B 78 2.24 -161.39 REMARK 500 GLU B 121 6.41 167.25 REMARK 500 LYS B 122 58.16 -114.78 REMARK 500 LYS B 123 -119.12 55.73 REMARK 500 ASP B 181 46.81 -152.15 REMARK 500 ASP B 200 79.11 56.19 REMARK 500 CYS B 218 159.03 76.77 REMARK 500 CYS B 218 148.45 76.78 REMARK 500 PHE B 291 -70.96 -40.12 REMARK 500 ASN B 370 73.41 -171.66 REMARK 500 ARG B 383 -82.68 -77.89 REMARK 500 HIS X 200 -57.16 -132.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 47 PRO A 48 36.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "BA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1386 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1387 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1388 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1389 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1385 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1386 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1387 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1388 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1389 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZRL A 1390 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZRL B 1390 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2UW9 RELATED DB: PDB REMARK 900 STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH 4-(4- CHLORO-PHENYL)-4- REMARK 900 (4-(1H-PYRAZOL-4-YL)-PHENYL)- PIPERIDINE REMARK 900 RELATED ID: 1O6K RELATED DB: PDB REMARK 900 STRUCTURE OF ACTIVATED FORM OF PKB KINASE DOMAIN S474D WITH GSK3 REMARK 900 PEPTIDE AND AMP-PNP REMARK 900 RELATED ID: 1GNG RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE 3BETA (GSK3) COMPLEX WITH FRATTIDE PEPTIDE REMARK 900 RELATED ID: 1H8F RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA. REMARK 900 RELATED ID: 1Q3W RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH ALSTERPAULLONE REMARK 900 RELATED ID: 3ZRK RELATED DB: PDB REMARK 900 IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK -3BETA REMARK 900 INHIBITORS REMARK 900 RELATED ID: 1I09 RELATED DB: PDB REMARK 900 STRUCTURE OF GLYCOGEN SYNTHASE KINASE-3 (GSK3B) REMARK 900 RELATED ID: 1O9U RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE REMARK 900 RELATED ID: 2X37 RELATED DB: PDB REMARK 900 STRUCTURE OF 4-(4-TERT-BUTYLBENZYL)-1-(7H-PYRROLO(2 ,3-D)PYRIMIDIN- REMARK 900 4-YL)PIPERIDIN-4-AMINE BOUND TO PKB REMARK 900 RELATED ID: 2JDR RELATED DB: PDB REMARK 900 STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH THE INHIBITOR A-443654 REMARK 900 RELATED ID: 1O6L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN ACTIVATED AKT/PROTEIN KINASE B (PKB-PIF REMARK 900 CHIMERA) TERNARY COMPLEX WITH AMP-PNP AND GSK3 PEPTIDE REMARK 900 RELATED ID: 1J1B RELATED DB: PDB REMARK 900 BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITHAMPPNP REMARK 900 RELATED ID: 1R0E RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH 3- INDOLYL-4- REMARK 900 ARYLMALEIMIDE INHIBITOR REMARK 900 RELATED ID: 2X39 RELATED DB: PDB REMARK 900 STRUCTURE OF 4-AMINO-N-(4-CHLOROBENZYL)-1-(7H- PYRROLO(2,3-D) REMARK 900 PYRIMIDIN-4-YL)PIPERIDINE-4- CARBOXAMIDE BOUND TO PKB REMARK 900 RELATED ID: 1Q41 RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH INDIRUBIN-3'-MONOXIME REMARK 900 RELATED ID: 1Q3D RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH STAUROSPORINE REMARK 900 RELATED ID: 2JLD RELATED DB: PDB REMARK 900 EXTREMELY TIGHT BINDING OF RUTHENIUM COMPLEX TO GLYCOGEN SYNTHASE REMARK 900 KINASE 3 REMARK 900 RELATED ID: 1Q5K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 INCOMPLEXED WITH REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2JDO RELATED DB: PDB REMARK 900 STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE -5- REMARK 900 SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO) ETHYL)AMIDE REMARK 900 RELATED ID: 1PYX RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH AMP-PNP REMARK 900 RELATED ID: 1Q4L RELATED DB: PDB REMARK 900 GSK-3 BETA COMPLEXED WITH INHIBITOR I-5 REMARK 900 RELATED ID: 1J1C RELATED DB: PDB REMARK 900 BINARY COMPLEX STRUCTURE OF HUMAN TAU PROTEIN KINASE I WITHADP REMARK 900 RELATED ID: 2XH5 RELATED DB: PDB REMARK 900 STRUCTURE OF 4-(4-TERT-BUTYLBENZYL)-1-(7H-PYRROLO(2 ,3-D)PYRIMIDIN- REMARK 900 4-YL)PIPERIDIN-4-AMINE BOUND TO PKB REMARK 900 RELATED ID: 1UV5 RELATED DB: PDB REMARK 900 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6- BROMOINDIRUBIN-3'- REMARK 900 OXIME REMARK 900 RELATED ID: 3ZRM RELATED DB: PDB REMARK 900 IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK -3BETA REMARK 900 INHIBITORS DBREF 3ZRL A 23 393 UNP P49841 GSK3B_HUMAN 23 393 DBREF 3ZRL B 23 393 UNP P49841 GSK3B_HUMAN 23 393 DBREF 3ZRL X 197 226 UNP Q92837 FRAT1_HUMAN 197 226 DBREF 3ZRL Y 197 226 UNP Q92837 FRAT1_HUMAN 197 226 SEQADV 3ZRL MET X 195 UNP Q92837 EXPRESSION TAG SEQADV 3ZRL ALA X 196 UNP Q92837 EXPRESSION TAG SEQADV 3ZRL MET Y 195 UNP Q92837 EXPRESSION TAG SEQADV 3ZRL ALA Y 196 UNP Q92837 EXPRESSION TAG SEQRES 1 A 371 PHE GLY SER MET LYS VAL SER ARG ASP LYS ASP GLY SER SEQRES 2 A 371 LYS VAL THR THR VAL VAL ALA THR PRO GLY GLN GLY PRO SEQRES 3 A 371 ASP ARG PRO GLN GLU VAL SER TYR THR ASP THR LYS VAL SEQRES 4 A 371 ILE GLY ASN GLY SER PHE GLY VAL VAL TYR GLN ALA LYS SEQRES 5 A 371 LEU CYS ASP SER GLY GLU LEU VAL ALA ILE LYS LYS VAL SEQRES 6 A 371 LEU GLN ASP LYS ARG PHE LYS ASN ARG GLU LEU GLN ILE SEQRES 7 A 371 MET ARG LYS LEU ASP HIS CYS ASN ILE VAL ARG LEU ARG SEQRES 8 A 371 TYR PHE PHE TYR SER SER GLY GLU LYS LYS ASP GLU VAL SEQRES 9 A 371 TYR LEU ASN LEU VAL LEU ASP TYR VAL PRO GLU THR VAL SEQRES 10 A 371 TYR ARG VAL ALA ARG HIS TYR SER ARG ALA LYS GLN THR SEQRES 11 A 371 LEU PRO VAL ILE TYR VAL LYS LEU TYR MET TYR GLN LEU SEQRES 12 A 371 PHE ARG SER LEU ALA TYR ILE HIS SER PHE GLY ILE CYS SEQRES 13 A 371 HIS ARG ASP ILE LYS PRO GLN ASN LEU LEU LEU ASP PRO SEQRES 14 A 371 ASP THR ALA VAL LEU LYS LEU CYS ASP PHE GLY SER ALA SEQRES 15 A 371 LYS GLN LEU VAL ARG GLY GLU PRO ASN VAL SER PTR ILE SEQRES 16 A 371 CYS SER ARG TYR TYR ARG ALA PRO GLU LEU ILE PHE GLY SEQRES 17 A 371 ALA THR ASP TYR THR SER SER ILE ASP VAL TRP SER ALA SEQRES 18 A 371 GLY CYS VAL LEU ALA GLU LEU LEU LEU GLY GLN PRO ILE SEQRES 19 A 371 PHE PRO GLY ASP SER GLY VAL ASP GLN LEU VAL GLU ILE SEQRES 20 A 371 ILE LYS VAL LEU GLY THR PRO THR ARG GLU GLN ILE ARG SEQRES 21 A 371 GLU MET ASN PRO ASN TYR THR GLU PHE LYS PHE PRO GLN SEQRES 22 A 371 ILE LYS ALA HIS PRO TRP THR LYS VAL PHE ARG PRO ARG SEQRES 23 A 371 THR PRO PRO GLU ALA ILE ALA LEU CYS SER ARG LEU LEU SEQRES 24 A 371 GLU TYR THR PRO THR ALA ARG LEU THR PRO LEU GLU ALA SEQRES 25 A 371 CYS ALA HIS SER PHE PHE ASP GLU LEU ARG ASP PRO ASN SEQRES 26 A 371 VAL LYS LEU PRO ASN GLY ARG ASP THR PRO ALA LEU PHE SEQRES 27 A 371 ASN PHE THR THR GLN GLU LEU SER SER ASN PRO PRO LEU SEQRES 28 A 371 ALA THR ILE LEU ILE PRO PRO HIS ALA ARG ILE GLN ALA SEQRES 29 A 371 ALA ALA SER THR PRO THR ASN SEQRES 1 B 371 PHE GLY SER MET LYS VAL SER ARG ASP LYS ASP GLY SER SEQRES 2 B 371 LYS VAL THR THR VAL VAL ALA THR PRO GLY GLN GLY PRO SEQRES 3 B 371 ASP ARG PRO GLN GLU VAL SER TYR THR ASP THR LYS VAL SEQRES 4 B 371 ILE GLY ASN GLY SER PHE GLY VAL VAL TYR GLN ALA LYS SEQRES 5 B 371 LEU CYS ASP SER GLY GLU LEU VAL ALA ILE LYS LYS VAL SEQRES 6 B 371 LEU GLN ASP LYS ARG PHE LYS ASN ARG GLU LEU GLN ILE SEQRES 7 B 371 MET ARG LYS LEU ASP HIS CYS ASN ILE VAL ARG LEU ARG SEQRES 8 B 371 TYR PHE PHE TYR SER SER GLY GLU LYS LYS ASP GLU VAL SEQRES 9 B 371 TYR LEU ASN LEU VAL LEU ASP TYR VAL PRO GLU THR VAL SEQRES 10 B 371 TYR ARG VAL ALA ARG HIS TYR SER ARG ALA LYS GLN THR SEQRES 11 B 371 LEU PRO VAL ILE TYR VAL LYS LEU TYR MET TYR GLN LEU SEQRES 12 B 371 PHE ARG SER LEU ALA TYR ILE HIS SER PHE GLY ILE CYS SEQRES 13 B 371 HIS ARG ASP ILE LYS PRO GLN ASN LEU LEU LEU ASP PRO SEQRES 14 B 371 ASP THR ALA VAL LEU LYS LEU CYS ASP PHE GLY SER ALA SEQRES 15 B 371 LYS GLN LEU VAL ARG GLY GLU PRO ASN VAL SER PTR ILE SEQRES 16 B 371 CYS SER ARG TYR TYR ARG ALA PRO GLU LEU ILE PHE GLY SEQRES 17 B 371 ALA THR ASP TYR THR SER SER ILE ASP VAL TRP SER ALA SEQRES 18 B 371 GLY CYS VAL LEU ALA GLU LEU LEU LEU GLY GLN PRO ILE SEQRES 19 B 371 PHE PRO GLY ASP SER GLY VAL ASP GLN LEU VAL GLU ILE SEQRES 20 B 371 ILE LYS VAL LEU GLY THR PRO THR ARG GLU GLN ILE ARG SEQRES 21 B 371 GLU MET ASN PRO ASN TYR THR GLU PHE LYS PHE PRO GLN SEQRES 22 B 371 ILE LYS ALA HIS PRO TRP THR LYS VAL PHE ARG PRO ARG SEQRES 23 B 371 THR PRO PRO GLU ALA ILE ALA LEU CYS SER ARG LEU LEU SEQRES 24 B 371 GLU TYR THR PRO THR ALA ARG LEU THR PRO LEU GLU ALA SEQRES 25 B 371 CYS ALA HIS SER PHE PHE ASP GLU LEU ARG ASP PRO ASN SEQRES 26 B 371 VAL LYS LEU PRO ASN GLY ARG ASP THR PRO ALA LEU PHE SEQRES 27 B 371 ASN PHE THR THR GLN GLU LEU SER SER ASN PRO PRO LEU SEQRES 28 B 371 ALA THR ILE LEU ILE PRO PRO HIS ALA ARG ILE GLN ALA SEQRES 29 B 371 ALA ALA SER THR PRO THR ASN SEQRES 1 X 32 MET ALA ASP ASP PRO HIS ARG LEU LEU GLN GLN LEU VAL SEQRES 2 X 32 LEU SER GLY ASN LEU ILE LYS GLU ALA VAL ARG ARG LEU SEQRES 3 X 32 HIS SER ARG ARG LEU GLN SEQRES 1 Y 32 MET ALA ASP ASP PRO HIS ARG LEU LEU GLN GLN LEU VAL SEQRES 2 Y 32 LEU SER GLY ASN LEU ILE LYS GLU ALA VAL ARG ARG LEU SEQRES 3 Y 32 HIS SER ARG ARG LEU GLN MODRES 3ZRL PTR A 216 TYR O-PHOSPHOTYROSINE MODRES 3ZRL PTR B 216 TYR O-PHOSPHOTYROSINE HET PTR A 216 16 HET PTR B 216 16 HET SO4 A1386 5 HET SO4 A1387 5 HET SO4 A1388 5 HET GOL A1389 6 HET ZRL A1390 17 HET SO4 B1385 5 HET SO4 B1386 5 HET SO4 B1387 5 HET GOL B1388 6 HET GOL B1389 6 HET ZRL B1390 17 HETNAM PTR O-PHOSPHOTYROSINE HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETNAM ZRL 7-BROMO-2-PYRIDIN-4-YL-5H-THIENO[3,2-C]PYRIDIN-4-ONE HETSYN PTR PHOSPHONOTYROSINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 5 SO4 6(O4 S 2-) FORMUL 8 GOL 3(C3 H8 O3) FORMUL 9 ZRL 2(C12 H7 BR N2 O S) FORMUL 16 HOH *198(H2 O) HELIX 1 1 ASN A 95 LEU A 104 1 10 HELIX 2 2 VAL A 139 ALA A 149 1 11 HELIX 3 3 PRO A 154 SER A 174 1 21 HELIX 4 4 LYS A 183 GLN A 185 5 3 HELIX 5 5 SER A 219 ARG A 223 5 5 HELIX 6 6 ALA A 224 PHE A 229 1 6 HELIX 7 7 SER A 236 GLY A 253 1 18 HELIX 8 8 SER A 261 GLY A 274 1 14 HELIX 9 9 THR A 277 ASN A 285 1 9 HELIX 10 10 PRO A 300 PHE A 305 1 6 HELIX 11 11 PRO A 310 ARG A 319 1 10 HELIX 12 12 THR A 324 ARG A 328 5 5 HELIX 13 13 THR A 330 ALA A 336 1 7 HELIX 14 14 HIS A 337 ASP A 345 5 9 HELIX 15 15 THR A 363 SER A 368 1 6 HELIX 16 16 ASN A 370 PRO A 372 5 3 HELIX 17 17 LEU A 373 ILE A 378 1 6 HELIX 18 18 ASN B 95 ARG B 102 1 8 HELIX 19 19 VAL B 139 ALA B 149 1 11 HELIX 20 20 PRO B 154 SER B 174 1 21 HELIX 21 21 LYS B 183 GLN B 185 5 3 HELIX 22 22 SER B 219 ARG B 223 5 5 HELIX 23 23 ALA B 224 PHE B 229 1 6 HELIX 24 24 SER B 236 GLY B 253 1 18 HELIX 25 25 SER B 261 GLY B 274 1 14 HELIX 26 26 THR B 277 ASN B 285 1 9 HELIX 27 27 PRO B 300 PHE B 305 1 6 HELIX 28 28 PRO B 310 LEU B 321 1 12 HELIX 29 29 THR B 324 ARG B 328 5 5 HELIX 30 30 THR B 330 ALA B 336 1 7 HELIX 31 31 HIS B 337 PHE B 339 5 3 HELIX 32 32 PHE B 340 ASP B 345 1 6 HELIX 33 33 ASN B 370 PRO B 372 5 3 HELIX 34 34 LEU B 373 ILE B 378 1 6 HELIX 35 35 PRO B 379 ARG B 383 5 5 HELIX 36 36 HIS X 200 SER X 209 1 10 HELIX 37 37 ASN X 211 HIS X 221 1 11 HELIX 38 38 ARG Y 201 SER Y 209 1 9 HELIX 39 39 ASN Y 211 HIS Y 221 1 11 SHEET 1 AA 7 THR A 38 PRO A 44 0 SHEET 2 AA 7 GLN A 52 GLY A 65 -1 O GLN A 52 N ALA A 42 SHEET 3 AA 7 GLY A 68 LEU A 75 -1 O GLY A 68 N GLY A 65 SHEET 4 AA 7 LEU A 81 GLN A 89 -1 O VAL A 82 N ALA A 73 SHEET 5 AA 7 VAL A 126 ASP A 133 -1 O VAL A 126 N GLN A 89 SHEET 6 AA 7 LEU A 112 SER A 118 -1 N ARG A 113 O VAL A 131 SHEET 7 AA 7 THR A 38 PRO A 44 -1 O THR A 43 N PHE A 115 SHEET 1 AB 3 GLU A 137 THR A 138 0 SHEET 2 AB 3 LEU A 187 LEU A 189 -1 O LEU A 189 N GLU A 137 SHEET 3 AB 3 LEU A 196 LEU A 198 -1 O LYS A 197 N LEU A 188 SHEET 1 AC 2 ILE A 177 CYS A 178 0 SHEET 2 AC 2 LYS A 205 GLN A 206 -1 O LYS A 205 N CYS A 178 SHEET 1 BA 7 THR B 38 PRO B 44 0 SHEET 2 BA 7 GLN B 52 GLY B 65 -1 O GLN B 52 N ALA B 42 SHEET 3 BA 7 GLY B 68 LEU B 75 -1 O GLY B 68 N GLY B 65 SHEET 4 BA 7 LEU B 81 LEU B 88 -1 O VAL B 82 N ALA B 73 SHEET 5 BA 7 VAL B 126 ASP B 133 -1 O LEU B 128 N VAL B 87 SHEET 6 BA 7 LEU B 112 SER B 119 -1 N ARG B 113 O VAL B 131 SHEET 7 BA 7 THR B 38 PRO B 44 -1 O THR B 43 N PHE B 115 SHEET 1 BB 3 GLU B 137 THR B 138 0 SHEET 2 BB 3 LEU B 187 LEU B 189 -1 O LEU B 189 N GLU B 137 SHEET 3 BB 3 LEU B 196 LEU B 198 -1 O LYS B 197 N LEU B 188 SHEET 1 BC 2 ILE B 177 CYS B 178 0 SHEET 2 BC 2 LYS B 205 GLN B 206 -1 O LYS B 205 N CYS B 178 LINK C SER A 215 N PTR A 216 1555 1555 1.33 LINK C PTR A 216 N ILE A 217 1555 1555 1.32 LINK C SER B 215 N PTR B 216 1555 1555 1.33 LINK C PTR B 216 N ILE B 217 1555 1555 1.32 CISPEP 1 GLN A 46 GLY A 47 0 -29.73 CISPEP 2 PRO A 48 ASP A 49 0 20.79 CISPEP 3 SER A 118 SER A 119 0 2.36 CISPEP 4 LYS B 91 ARG B 92 0 4.00 SITE 1 AC1 5 ARG A 96 ARG A 180 LYS A 205 ASN A 213 SITE 2 AC1 5 VAL A 214 SITE 1 AC2 1 ARG A 96 SITE 1 AC3 4 VAL A 208 ARG A 209 HOH A2043 ARG B 209 SITE 1 AC4 2 PRO A 154 VAL A 155 SITE 1 AC5 5 ARG B 96 ARG B 180 LYS B 205 ASN B 213 SITE 2 AC5 5 VAL B 214 SITE 1 AC6 1 ARG B 96 SITE 1 AC7 1 ARG B 278 SITE 1 AC8 4 LYS A 297 VAL B 155 ILE B 156 HOH B2095 SITE 1 AC9 2 ARG B 141 GLN B 185 SITE 1 BC1 10 PHE A 67 VAL A 70 LYS A 85 ASP A 133 SITE 2 BC1 10 TYR A 134 VAL A 135 LEU A 188 ASP A 200 SITE 3 BC1 10 HOH A2039 HOH A2040 SITE 1 BC2 11 PHE B 67 VAL B 70 ALA B 83 LYS B 85 SITE 2 BC2 11 ASP B 133 TYR B 134 VAL B 135 LEU B 188 SITE 3 BC2 11 ASP B 200 HOH B2004 HOH B2036 CRYST1 153.231 153.231 201.729 90.00 90.00 120.00 H 3 2 36 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006526 0.003768 0.000000 0.00000 SCALE2 0.000000 0.007536 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004957 0.00000